We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms.
- Authors
Modinos, Gemma; Şimşek, Fatma; Horder, Jamie; Bossong, Matthijs; Bonoldi, Ilaria; Azis, Matilda; Perez, Jesus; Broome, Matthew; Lythgoe, David J; Stone, James M; Howes, Oliver D; Murphy, Declan G; Grace, Anthony A; Allen, Paul; McGuire, Philip
- Abstract
Background: Whilst robust preclinical and postmortem evidence suggests that altered GABAergic function is central to the development of psychosis, little is known about whether it is altered in subjects at ultra-high risk of psychosis, or its relationship to prodromal symptoms. Methods: Twenty-one antipsychotic naïve ultra-high risk individuals and 20 healthy volunteers underwent proton magnetic resonance imaging at 3T. Gamma-aminobutyric acid levels were obtained from the medial prefrontal cortex using MEGAPRESS and expressed as peak-area ratios relative to the synchronously acquired creatine signal. Gamma-aminobutyric acid levels were then related to severity of positive and negative symptoms as measured with the Community Assessment of At-Risk Mental States. Results: Whilst we found no significant difference in gamma-aminobutyric acid levels between ultra-high risk subjects and healthy controls (P = .130), in ultra-high risk individuals, medial prefrontal cortex GABA levels were negatively correlated with the severity of negative symptoms (P = .013). Conclusion: These findings suggest that gamma-aminobutyric acidergic neurotransmission may be involved in the neurobiology of negative symptoms in the ultra-high risk state.
- Subjects
GABA; AMINO acid neurotransmitters; MAGNETIC resonance; MAGNETIC fields; NEURAL development
- Publication
International Journal of Neuropsychopharmacology, 2018, Vol 21, Issue 2, p114
- ISSN
1461-1457
- Publication type
Article
- DOI
10.1093/ijnp/pyx076